More than 40 variations of intercellular organelle transfer, such as a mitochondria or lysosome originating in one cell being transported to another cell, have been described. We review the mechanisms and subcellular structures by which, and conditions under which, transfer occurs, with particular attention paid to the role of external cell stress in activating transfer. We propose a research agenda for answering key questions in this burgeoning field.
Since the report by Rustom et al. that cultured cells are capable of forming "nanotubes" that span up to several cell diameters in length and that they use these conduits to transport whole organelles between cells (26), the last decade has seen a burst of interest in the phenomenon of intercellular organelle exchange and transfer. Traditionally considered processes of intercellular communication include cell contact-dependent and paracrine receptor-ligand interactions, synaptic vesicle release and uptake, and ion flow through gap junctions (2) . However, organelle transfer is in a sense a special form of intercellular communication, because it represents the transfer not only of signals but also of defined intracellular structures. The study of intercellular organelle transfer is new and has thus far raised more questions than provided answers. In particular, the issues relate to whether intercellular organelle transfer contributes to the cell's adaptive response to external stress and whether the transfer enhances cell survival and function. In this review, we summarize current understanding of intercellular organelle transfer, including the types of cells and organelles in which the transfer is described, the effects the transfer has on donor and recipient cells, the importance of external stress in activating the transfer, the signaling pathways and cellular machinery involved, and, finally, future research directions that might increase understanding of this phenomenon.
Intercellular Organelle Transfer: The Basics
More than 40 variations of intercellular organelle transfer have been described, including endoplasmic reticulum/Golgi bodies, endosomes, lysosomes or the lysosome-related melanosome, and mitochondria originating in one cell (organelle donor) and being transported to another (organelle recipient). Table 1 summarizes the known instances of intercellular organelle transfer. 1 Five general observations regarding this phenomenon can be made.
First, in vitro intercellular organelle transfer has been described in a highly diverse assortment of cell types, including human and rodent, differentiated and multipotent, malignant and benign, epithelial and mesenchymal, and neuronal. Thus it is safe to conclude that the capability of one cell to donate or receive an organelle from another cell is clearly widespread throughout mammalian cell types in culture. Yet, importantly, intercellular organelle transfer is not universal. For example, although mesenchymal stem cells and fibroblasts donate mitochondria to mitochondria-deficient lung adenocarcinoma cells in culture, platelets may not (27a) . There are numerous examples of both homotypic (mesenchymal stem cell to mesenchymal stem cell) and heterotypic (mesenchymal stem cell to cardiomyocyte) organelle transfer between cells derived from both same and different species. Moreover, there are several reports where only one type of organelle is transferred between two given cell types, whereas there are others in which multiple types of organelles are transferred simultaneously. Undoubtedly, the list of cell types and cellular organelles known to participate in organelle transfer will continue to grow.
Second, the term "transfer" defines a process in which organelles are donated from one cell to another by ATP-dependent mechanisms that engage dedicated cytoskeletal and associated cell machinery. This definition of transfer excludes passive transport of cargo between connected cells (10) or passive uptake from the extracellular environment (27a). Moreover, there are instances of bidirectional transfer of organelles in which two cells both donate to and receive organelles from each other (11, 34) , and of strictly unidirectional transfer in which one cell type always donates organelles and the other always receives them (16) .
Third, from the initial report of intercellular organelle transfer via nanotubes, and also from subsequent reports, it is clear that intercellular transfer of whole organelles occurs concomitantly with transfer of cytosol and plasma membrane components (8) , as well as of small molecules and ions (32) .
Fourth, the frequency and efficacy with which cells transfer organelles varies across cell types and culture conditions. In the initial report of nanotube-mediated intercellular organelle transfer in rat pheocromocyotma cells, 10% of cultured cells received a transferred organelle (26) . Subsequent reports more or less confirm this transfer rate (5, 34) . Among cell subsets that form nanotube connections, up to three-quarters participate in organelle transfer (26) at transfer rates of 1-15 m/min (5, 10, 26, 31) . Organelle transfer commences within hours after cell plating (5, 26) , reaching a peak in 2-3 days (11, 24, 34) . Fifth, the vast majority of reports of intercellular organelle transfer have been obtained through studies in vitro (17) . Exceptions are a report that a canine venereal tumor acquires mitochondria from its host (25) and that exogenously administered bone marrow-derived mesenchymal stem cells donate mitochondria to injured alveolar epithelial cells of the mouse lung (12) .
The Consequences of Intercellular Organelle Transfer
Intercellular organelle transfer has been demonstrated to be crucial to several experimental models of cell survival under external stress. However, evidence for its role in cellular reprogramming is less robust.
Enhancing Probability of Cell Survival
Spees et al. developed A549 cells devoid of intrinsic mitochondrial function by depleting mitochondrial DNA through weeks-long treatment with ethidium bromide. These cells were only capable of expansion in a permissive medium supplemented with pyruvate and uridine to enhance glycolysis. Most did not survive in standard media. When co-cultured with mesenchymal stem cells or fibroblasts that donated functional mitochondria, mitochondria-deficient A549 cells acquired mitochondria, established aerobic respiration, and proliferated at normal rates in standard media. Mitochondrial acquisition by A549 cells increased ATP, oxygen consumption, and membrane potential and decreased lactate production consistent with return of normal mitochondrial function in the rescued clones (27a).
Work in our laboratory has demonstrated that mitochondrial transfer from mesenchymal stem cells to alveolar epithelial cells protects against endotoxin-induced acute lung injury in mice, preserving cellular ATP production, attenuating the decline in surfactant production and enhancing mouse survival. Transfer of viable mitochondria is necessary for these protective effects. No protection is afforded by treatment with mesenchymal stem cells that are fully functional yet incapable of organelle transfer (connexin-43 mutants) or by those that are capable of organelle transfer but contain dysfunctional mitochondria. In sepsisinjured lungs, exogenous MSCs appear to transfer all of their mitochondria to the alveolar epithelium.
The subsequent fate of the mitochondria-depleted MSC cell body presently remains unclear (12) .
Transfer of lysosomes has also been shown to enhance cell survival under certain conditions of stress. Yasuda et al. (34) demonstrated that treatment with glycated collagen type I induces lysosomal dysfunction (an increase in lysosomal pH and decreased autophagy), leading to reduced survival in human umbilical vein endothelial cells. When endothelial progenitor cells are added to create a co-culture, a protective effect is seen, mediated by the visualized transfer of lysosomes from the endothelial progenitor cell to the human umbilical vein endothelial cell. This protective effect is lost when lysosomal transfer is prevented by the inhibition of nanotube formation (34) .
Although most reports note that mitochondrial transfer through nanotubes is beneficial for cell survival, in high concentrations, donated mitochondria might be directly cytotoxic. When rat mesenchymal stem cells and rat lung microvascular endothelial cells are co-cultured in a 1:1 ratio, the mesenchymal stem cells induce apoptosis of the endothelial cells. Mitochondrial transfer from the mesenchymal stem cell to the endothelial cell has been visualized in this experimental setting. These studies provide suggestive evidence that this mitochondrial transfer is an essential mediator of the observed cytotoxicity, which occurs through a cell contact-dependent increase in reactive oxygen species in the endothelial cell (22) .
Cellular Reprogramming
Intercellular organelle transfer has been studied extensively in the context of cellular reprogramming, and several reports have detailed instances in which a cell type's differentiation or dedifferentiation is accompanied by intercellular organelle transfer. Plotnikov et al. (23, 24) show that coculturing mesenchymal stem cells with renal tubular cells or cardiomyocytes leads to mitochondrial transfer from the mesenchymal stem cell to the differentiated cell and that, in time, the mesenchymal stem cell expresses proteins characteristic of the differentiated cell (Tamm-Horfsall protein and heavy chain myosin, respectively). However, it is unknown whether selectively blocking the mitochondrial transfer would be sufficient to inhibit reprogramming of the mesenchymal stem cell.
Acquistapace et al.
(1) demonstrated that terminally differentiated mouse cardiomyocytes can assume a more progenitor-like state when cocultured with human adipose-derived or bone marrow-derived stem cells. The process involves cell fusion and mitochondrial transfer from adiposederived cells to cardiomyocytes. These effects require functional mitochondria, since there is a marked reduction in the reprogramming process when the stem cells are rendered mitochondrially dysfunctional by treatment with ethidium bromide (1). However, it remains unclear whether the reprogramming was hindered by a lack of functional mitochondria in adipose-derived cells or whether there was a failure of mitochondrial transfer from adipose-derived cells to cardiomyocytes.
Vallabhaneni et al. (29) show that co-culturing mesenchymal stem cells with vascular smooth muscle cells increases the proliferation rate of the mesenchymal stem cells and is accompanied by mitochondrial transfer from the vascular smooth muscle cell to the mesenchymal stem cell. However, the enhancement of mesenchymal stem cell proliferation fails to occur when mitochondrial transfer is prevented by blocking nanotube formation or when the transferred mitochondria are dysfunctional due to ethidium bromide pretreatment (29) .
Although most studies of intercellular organelle transfer focus on the beneficial effects of the transfer, it is less clear whether intercellular organelle transfer contributes to pathology. Kadiu and Gendelman demonstrate that macrophages in vitro sprout nanotubes, which facilitate the exchange of endosomes and lysosomes between cells. HIV-1 may package in these endosomes and spread from one macrophage to the next (14) . It has also been shown that the nanotubes that are capable of serving as conduits for intercellular organelle transfer can also be "hijacked" for spreading of Mycobacterium bovis between macrophages (21) or prions between neurons (9). Lou et al. (18, 19) have shown that mitochondrial exchange occurs between pleural mesothelioma cells in vitro. However, it is not known whether selectively interfering with this mitochondrial exchange impacts cancer cell survival or proliferation (18, 19) .
The Connection Between Cellular Stress and Intercellular Organelle Transfer
Emerging understanding indicates that cell stress might be a major determinant of intercellular organelle transfer. The transfer of the melanosome from the melanocyte to the keratinocyte, a physiological process that regulates skin and hair pigmentation, is enhanced by UV stress (27) . When human umbilical vein endothelial cells (HUVECs) and mouse endothelial progenitor cells (EPCs) are co-cultured in standard media, 17% of the HUVECs receive mitochondria from EPCs after 24 h. This transfer doubles when the HUVECs are stressed by exposure to the cytotoxic drug adriamycin (35) . Of note, under these conditions, mitochondrial transfer is unidirectional, from the EPC to the HUVEC. However, after 72 h of co-culture, bi-directional exchange of lysosomes occurs under basal conditions, such that ϳ15% of EPCs receive lysosomes from HUVECs and vice versa (34) . When HUVECs are pretreated with glycated collagen type I, which induces lysosomal dysfunction, the fraction of cells participating in lysosomal exchange doubles. Interestingly, the increase is driven entirely by lysosomal transfer in one direction, from the EPC to the HUVEC (34) .
Under some conditions, cell stress might be an absolute prerequisite for organelle transfer to occur. Wang et al. (31) 
Work in our laboratory suggests that cell damage is essential for mitochondrial transfer in vivo. In mice, mesenchymal stem cells injected into the trachea successfully transfer mitochondria to alveolar epithelial cells of the lung when it is injured with endotoxin but not when it is uninjured (12) . When injected into the healthy lung, the mesenchymal stem cells quickly migrate to the interstitium without forming the physical attachments to the alveolar epithelium that are necessary to facilitate mitochondrial transfer. The failure to transfer mitochondria to healthy alveolar epithelium is probably caused by a general lack of interaction between mesenchymal stem cells and alveolar epithelium in the absence of damage signals, but it is possible that the specific lack of a signal needed to spur mitochondrial transfer is also a contributing factor. Identifying signals that facilitate mitochondrial transfer after mesenchymal stem cell attachment to the target tissue is of potential importance to the goal of engineering exogenous stem cells for clinical use.
Taken together, these results suggest that intercellular organelle transfer can occur in many cell types under basal conditions. However, it seems that stem cells possess mechanisms for upregulating organelle donation in response to injury signals originating from the recipient cell. Although organelle transfer may proceed in a bi-directional manner between participating cells, the stressed cell tends to be the net recipient of organelles, as opposed to being the net donor. That a mammalian cell under threat from environmental stress becomes more likely to accept organelles from a neighboring cell, as opposed to "shedding" its own organelles, is perhaps an important adaptation to higher multicellular organization and cooperation. This stands in contrast to the behavior of unicellular organisms, such as the ciliated protozoa, which perform vigorous extrusion of mitochondria in response to heat shock or attack by surface-targeted antibodies (4).
The Mechanics of Intercellular Organelle Transfer
The study of intercellular organelle transfer has burgeoned in parallel with the study of "tunneling nanotubes," the principal conduit through which organelles travel from one cell to the other (for an excellent review, see Ref. 20) . Tunneling nanotubes were initially defined as "ultrafine intercellular structures" with diameters of 50 -200 nm and lengths spanning several cell diameters that connect cells without contacting the substratum (26) . Subsequent reports confirm that these characteristics are shared by nanotubes across diverse cell types and culture conditions (16, 31) . Those nanotubes, which serve as conduits specifically for mitochondrial transfer, might be larger in diameter than 200 nm to accommodate these larger organelles.
In multiple studies, organelle motion in nanotubes has been visualized during the process of intercellular organelle transfer (5, 10, 26) . Realtime studies by fluorescence microscopy indicate that that the nanotube protrudes from the initiating cell as an extension of the plasma membrane. The leading edge of the protrusion makes contact and then fuses with the plasma membrane of the recipient cell, creating a contiguous path formed by cytosol, actin cytoskeleton, and the surrounding plasma membrane. Organelles enter this conduit from the organelle-donating cell, traverse the conduit along the actin cytoskeleton, and are deposited in the recipient cell's cytosol (26) .
Two lines of evidence suggest that nanotubes are both sufficient and necessary as the structural bridge for intercellular organelle transfer. They are sufficient because, when cultured under cooled conditions in which nanotube formation occurs, but other transfer processes such as endocytosis, exocytosis, and phagocytosis are blocked, intercellular organelle transfer is sustained between rat pheocromocytoma cells and rat kidney cells (10, 26) . However, the mechanism that preserves nanotube transport under cooled conditions remains unclear. Nanotubes are necessary because, when cultured under conditions that prevent nanotube formation, such as continuous physical shaking of the cells that breaks nanotubes, or chemical inhibition of nanotube formation, intercellular organelle transfer is substantially reduced in proportion to the reduction of nanotube formation (5, 10, 26) .
The mechanisms of nanotube formation and their composition are beginning to be understood. Several reports indicate that nanotubes contain F-actin but not microtubules, although Onfelt et al. (21) report a special type of "thick nanotube" of Ͼ700 nm that contains both F-actin and microtubules. Bukoreshtliev et al. (5) note that the majority of nanotubes form by a process in which a cell extends a filopodium to make contact with a neighboring cell. The filopodium then retracts, leaving a nanotube connection between the cells. In a minority of cases, nanotubes form as the residual connection between two cells that were in ZO-1 ezrin F-actin FIGURE 1. Proposed model of organelle transfer from a stem cell to a differentiated epithelial cell in culture A: the epithelial cell releases unknown protein or metabolite "damage" signals into the culture medium in response to stress in the extracellular environment (step 1). The stem cell receives the epithelial cell damage signal, stimulating nanotube formation (step 2). B: the stem cell projects a nanotube toward the epithelial cell, creating a membrane-contiguous conduit between the cells (step 3).
Step 3 can occur in the absence of a damage signal, but occur with greater frequency when one is present. The proteins ezrin and zona occludens-1 (ZO-1) anchor the nanotube at its base on the stem cell, and the nanotube is supported by an F-actin cytoskeleton attached to myosin. C: an organelle, in this case a mitochondrion, enters the nanotube from the stem cell, is attached to the actin-myosin cytoskeleton by unknown attachment proteins, and is propelled by the myosin along the length of the nanotube until it is deposited in the cytosol of the epithelial cell (step 4). Note that the nanotube is sprouted by the stem cell, which acts as the organelle donor, whereas the distressed epithelial cell is the organelle recipient. (32) showed that cells separated by a distance of Ͼ100 m cannot form interconnecting nanotubes, which likely explains the observed substantial reduction in intercellular organelle transfer between two cell populations when they are physically separated by this distance or greater (23, 24) .
Nanotubes impart directionality on intercellular organelle transfer. For any one nanotube, organelles travel in one direction, from the cell that sprouted the nanotube to the cell that received the nanotube and not vice versa (26) . Organelles are transferred by myosin engagement, with the F-actin skeleton of the nanotube. Blocking myosin involvement can impede organelle transfer, or transfer can be enhanced by specifically blocking retrograde movement powered by myosin (10) . These findings suggest that a complex interplay of mechanisms regulate anterograde and retrograde organelle movement toward the recipient cell. These mechanisms remain to be elucidated. Fascin is expressed at the base of the nanotube, and ezrin and zona occludens-1 occur at the site of extrusion from the plasma membrane (19) ; it is almost certain that Rho GTPases play some role (3), although ␤-catenin and E-cadherin are notably absent (19) . Proteins that connect membrane-bound organelles to myosin and support organelle movement along the nanotube remain undefined. However, the goal of defining these proteins may be within reach since the "nanotube proteome" consisting of 275 proteins is now defined (15) . FIGURES 1-3 propose an integrated model of the key structural and signaling mediators of intercellular organelle transfer along nanotubes.
A potential explanation for the finding that intercellular organelle transfer occurs at a basal rate that can then be further stimulated by exposure to cell stress is that this is a property of nanotube formation itself. In cultured pleural mesothelioma cells, nanotube formation increases in acidified, hyperglycemic, or low-serum media, as well as when the media is supplemented with cytokines known to facilitate epithelial-to-mesenchymal transition (EGF, FGF, TGFB-3) (19) . Similarly, treatment with the antibiotic zeocin stimulates nanotube formation in human renal tubular epithelial cells (8) .
Wang et al. (31) showed that, in rat hippocampal neurons and astrocytes, nanotube formation is dependent on activation of the pro-apoptotic p53 protein, which through EGFR activates Akt/MTOR/ PI3K pathways to initiate nanotube formation. Subsequently, they have demonstrated that the direction of nanotube formation depends on the establishment of a gradient in the concentration of the protein S100A4, with the nanotube-initiating cell having low levels of S100A4 relative to the nanotube-receiving cell. They observed that the activation of caspase-3, a downstream effector of A: neuron A is damaged by exposure to stress in the extracellular environment. B: in response, p53 is activated in neuron 1, initiating a signaling cascade through activation of EGFR, which in turn activates the PI3K/Akt/mTOR pathway, which in turn activates caspase 3, which cleaves S100A4, reducing the concentration of S100A4, allowing the damaged neuron 1 to sprout a nanotube in the direction of the undamaged, relatively S100A4-rich neuron 2. C: an organelle, in this case a mitochondrion, enters the nanotube from neuron 1, is attached to the actin-myosin cytoskeleton by unknown attachment proteins, and is propelled by the myosin along the length of the nanotube until it is deposited in the cytosol of neuron 2. Note that the nanotube is sprouted by the damaged neuron, which acts as the organelle donor, whereas the uninjured neuron 2 is the organelle recipient.
p53 under conditions of cell stress, cleaves S100A4, leading to a decrease in S100A4 in the injured cell, which induces that cell to initiate nanotube formation (28) . Consistently, they observed nanotube formation to be a property of the stressed (i.e., p53-activated) cell itself, not its healthy neighbors, even demonstrating that exposing healthy cells to the medium in which stressed cells were cultured does not prompt them to form nanotubes (31) .
A paradox arises from these observations. On the one hand, as discussed in the previous section, mitochondria and lysosomes tend to be transferred with directional specificity from the uninjured to the injured cell. Yet, in a pair of cells connected by nanotubes, the cell that sprouts the nanotube is the organelle donor, whereas the other cell is the recipient. This is difficult to square with the finding that the stressed cell, which would be expected to be primarily an organelle recipient, is the cell that sprouts the nanotube, since nanotube sprouting is presumably the behavior primarily of an organelle donor. We await further experiments to resolve these conflicting models of intercellular organelle transfer via nanotubes. Perhaps a partial explanation is that signaling mechanisms that govern organelle transfer are essentially different for transfer from progenitor to differentiated cells vs. transfer among two differentiated cells, such as neurons.
Nanotubes have been identified in live tissues, including between cardiomyocytes and fibroblasts in the adult mouse heart (11), in the tumors of patients with pleural mesothelioma and poorly differentiated lung adenocarcinoma (19) , and in dendritic cells in the mouse cornea (6). However, there are likely important differences in the composition and characteristics of nanotubes in vivo and in vitro. For example, nanotubes that withstand the constant motion of the beating heart must in some way differ from those that are highly fragile when exposed to gentle shaking of the culture medium (10, 26) . Moreover, it has not been demonstrated that nanotubes play as essential a role in intercellular organelle transfer in vivo. They are strikingly absent in the one known example of endogenous intercellular organelle transfer, that of the melanosome. Wu et al. (33) recently described this process, and it involves adhesion between a melanocyte dendrite and keratinocyte, thinning of the dendrite behind its tip, abscission of the dendrite tip in contact with the keratinocyte, and finally phagocytosis of the extracellular package by the keratinocyte. In the case of mitochondrial transfer from mesenchymal stem cells to injured alveolar epithelial cells in the mouse lung, the mesenchymal cells form processes that contain mitochondria. However, the processes seem not to be the specific mechanism for the mitochondrial transfer. Rather, mesenchymal stem cells release vesicles containing mitochondria, which are engulfed by the epithelial cells in an endocytosisdependent manner, which can be blocked by the dynamin inhibitor dynasore (12) .
These observations raise the possibility that intercellular organelle transfer in vivo, to the extent it occurs, involves somewhat different cellular machinery than that described in vitro. This is not surprising, given a growing understanding that living organisms use a variety of mechanisms to communicate complex macromolecules over long distances, even transporting miRNA through the plasma via HDL (30) .
Unanswered Questions and a Research Agenda
The most pressing question in the field of intercellular organelle transfer is: To what extent does this phenomenon occur in vivo? Visualizing intercellular organelle transfer in real time in the intact living organism remains a major methodological challenge, although doing so in the ex vivo perfused organ is feasible, particularly with the provision of exogenous A: the epithelial cell is damaged by release of TNF-␣ by leukocytes as part of the systemic immune response to infection. B: in response to injury, the epithelial cell increases expression of connexin-43 (Cx43). The exogenously administered stem cell also expresses Cx43. C: the stem cell sprouts a nanotube toward the injured epithelial cell dependent on Cx43 homotypic interaction. Once the nanotube connection is established, there is bidirectional exchange of unknown signaling molecules. D: in response to signals from the epithelial cell, the stem cell releases a membrane-coated microvesicle that encases a membrane-bound organelle, in this case a mitochondrion, onto the surface of the epithelial cell, which then engulfs the microvesicle and its mitochondrion cargo through dynamin-dependent endocytosis. Note that the Cx43-dependent stabilizing interaction between stem cell and epithelial cell occurs only in the presence of epithelial cell damage.
organelle donor cells, which can be fluorescently labeled (12) . However, these studies do not clarify whether intercellular organelle transfer occurs endogenously. For example, do mesenchymal stem cells transfer mitochondria to hematopoietic cells in their natural bone marrow niche? And, if so, under what circumstances? Future studies might address this question in the context of specific cell types such as multipotent adult stem cells, mesenchymal stromal cells surrounding epithelial parenchyma in various organs, fibroblasts, and hematopoietic stem cells that are likely to be organelle donors.
Future research also needs to address the mechanisms that couple organelle transfer and nanotube formation. Importantly, it is not clear whether the two processes are interdependent, and, if so, how the interdependence is set up. Gurke et al. (10) showed that the myosin inhibitor BDM increases nanotube formation while decreasing organelle transfer, suggesting that the processes might be mechanistically distinct. However, it is not clear whether organelle transfer independently evolved as an adaptive mechanism.
Finally, future therapeutic implications of this research need to consider strategies to pharmacologically augment intercellular organelle transfer when desirable (i.e., to replenish dysfunctional mitochondrial and lysosomes in the cell under stress) or block its occurrence when it is deleterious, such as in the spread of infection or the maintenance of malignant cells. The reports reviewed here suggest that cell stress is a powerful stimulus for intercellular organelle transfer, and much work has already been done to elucidate its key functional regulators and associated cytoskeletal machinery. Yet, we are far from a full, detailed delineation of the protein interactions and signaling cascades involved in a transfer event. Ⅲ No conflicts of interest, financial or otherwise, are declared by the author(s).
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